Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Nuvation Bio (NUVB) Interest Expenses (2024 - 2026)

Nuvation Bio has reported Interest Expenses over the past 3 years, most recently at $6.7 million for Q1 2026.

  • Quarterly Interest Expenses rose 12322.22% to $6.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $22.4 million through Mar 2026, up 5567.85% year-over-year, with the annual reading at $13.7 million for FY2025, 3912.32% up from the prior year.
  • Interest Expenses was $6.7 million for Q1 2026 at Nuvation Bio, down from $10.1 million in the prior quarter.
  • Over five years, Interest Expenses peaked at $10.1 million in Q4 2025 and troughed at $54000.0 in Q1 2025.
  • The 3-year median for Interest Expenses is $276500.0 (2024), against an average of $2.8 million.
  • Year-over-year, Interest Expenses skyrocketed 218.94% in 2025 and then surged 12322.22% in 2026.
  • A 3-year view of Interest Expenses shows it stood at $89000.0 in 2024, then surged by 11291.01% to $10.1 million in 2025, then tumbled by 33.83% to $6.7 million in 2026.
  • Per Business Quant, the three most recent readings for NUVB's Interest Expenses are $6.7 million (Q1 2026), $10.1 million (Q4 2025), and $5.1 million (Q3 2025).